UNICA IRIS Institutional Research Information System

PANI, ANTONELLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 87.300
NA - Nord America 6.887
AS - Asia 4.183
SA - Sud America 1.248
AF - Africa 146
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 3
Totale 99.779
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 85.615
US - Stati Uniti d'America 6.746
SG - Singapore 1.686
CN - Cina 1.087
BR - Brasile 967
VN - Vietnam 569
SE - Svezia 473
DE - Germania 246
FR - Francia 230
FI - Finlandia 210
HK - Hong Kong 202
GB - Regno Unito 137
UA - Ucraina 127
AR - Argentina 118
BD - Bangladesh 92
IN - India 90
KR - Corea 65
AT - Austria 60
CA - Canada 60
ID - Indonesia 54
NL - Olanda 54
MX - Messico 52
MA - Marocco 47
EC - Ecuador 46
IQ - Iraq 44
JP - Giappone 34
TR - Turchia 33
ZA - Sudafrica 32
PK - Pakistan 31
CO - Colombia 28
PH - Filippine 27
VE - Venezuela 25
RU - Federazione Russa 23
CL - Cile 22
PL - Polonia 21
ES - Italia 17
PY - Paraguay 17
SA - Arabia Saudita 17
UZ - Uzbekistan 17
EG - Egitto 14
AE - Emirati Arabi Uniti 12
DZ - Algeria 11
AU - Australia 10
AZ - Azerbaigian 10
BE - Belgio 10
JO - Giordania 10
NP - Nepal 10
TW - Taiwan 10
BG - Bulgaria 9
IE - Irlanda 9
PE - Perù 9
TN - Tunisia 9
UY - Uruguay 9
IL - Israele 8
IR - Iran 8
KZ - Kazakistan 8
PS - Palestinian Territory 8
ET - Etiopia 7
LT - Lituania 7
MY - Malesia 7
PT - Portogallo 7
DK - Danimarca 6
KE - Kenya 6
OM - Oman 6
AL - Albania 5
BO - Bolivia 5
CR - Costa Rica 5
JM - Giamaica 5
KG - Kirghizistan 5
NI - Nicaragua 5
BH - Bahrain 4
CZ - Repubblica Ceca 4
DO - Repubblica Dominicana 4
KW - Kuwait 4
LB - Libano 4
LV - Lettonia 4
PA - Panama 4
QA - Qatar 4
SN - Senegal 4
AO - Angola 3
BA - Bosnia-Erzegovina 3
CH - Svizzera 3
HU - Ungheria 3
KH - Cambogia 3
RS - Serbia 3
TH - Thailandia 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
BW - Botswana 2
GE - Georgia 2
GR - Grecia 2
GT - Guatemala 2
HN - Honduras 2
LA - Repubblica Popolare Democratica del Laos 2
NZ - Nuova Zelanda 2
RO - Romania 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SO - Somalia 2
TT - Trinidad e Tobago 2
Totale 99.757
Salva come PNG Salva come JPEG
Città #
Cagliari 81.567
Uta 3.310
Singapore 783
Fairfield 727
Ashburn 676
Dallas 628
San Jose 407
Boardman 359
Nyköping 335
Woodbridge 328
Seattle 296
Houston 290
Cambridge 264
Wilmington 242
Ho Chi Minh City 210
Hong Kong 187
Chandler 184
Helsinki 174
Beijing 173
Ann Arbor 146
Los Angeles 144
Council Bluffs 142
Lauterbourg 137
Santa Clara 136
The Dalles 124
Shanghai 98
Jacksonville 94
Dearborn 92
Hanoi 86
Rome 85
New York 82
Hefei 81
Boston 77
Buffalo 75
São Paulo 74
Nanjing 68
Dong Ket 64
Seoul 63
Milan 52
Munich 49
San Diego 48
Frankfurt am Main 44
Nuremberg 39
Orem 38
Chicago 36
London 32
Rio de Janeiro 31
Belo Horizonte 30
Guangzhou 28
Tokyo 27
Casablanca 26
Vienna 26
Bologna 23
Jiaxing 23
Montreal 23
Phoenix 23
Hebei 22
Lappeenranta 22
Redwood City 22
Toronto 22
Brasília 21
Chennai 21
Nanchang 21
Redondo Beach 21
Baghdad 19
Da Nang 19
Guayaquil 19
Johannesburg 19
Haiphong 18
Naples 18
Sèlegas 18
Changsha 17
Bari 16
Tashkent 16
Tianjin 16
Brooklyn 15
Curitiba 15
Warsaw 15
Atlanta 14
Biên Hòa 14
Paris 14
Buenos Aires 13
Norwalk 13
Quito 13
Santiago 13
Sassari 13
Catania 12
Lahore 12
Manchester 12
Mexico City 12
Shenyang 12
Guarulhos 11
Mountain View 11
Tampa 11
Amsterdam 10
Can Tho 10
Denver 10
Dhaka 10
Goiânia 10
Jakarta 10
Totale 94.278
Salva come PNG Salva come JPEG
Nome #
Overexpression of the cytokine BAFF and autoimmunity risk 4.105
Duration of lithium treatment is a risk factor for reduced glomerular function: a cross-sectional study 3.754
Renal function during long-term lithium treatment: a cross-sectional and longitudinal study 3.701
Circulating antithyroid antibodies contribute to the decrease of glomerular filtration rate in lithium-treated patients: a longitudinal study 2.986
KIR and their HLA Class I ligands: Two more pieces towards completing the puzzle of chronic rejection and graft loss in kidney transplantation 2.910
Long-term lithium and estimated glomerular filtration rate 2.909
Role of human leukocyte antigen-G 14-base pair polymorphism in kidney transplantation outcomes 2.108
Children of a lesser god or miracles? An emotional and behavioural profile of children born to mothers on dialysis in Italy: A multicentre nationwide study 2000-12 2.011
Risk of adverse pregnancy outcomes in women with CKD 1.604
Kidney size in relation to ageing, gender, renal function, birthweight and chronic kidney disease risk factors in a general population 1.582
Vegan-vegetarian low-protein supplemented diets in pregnant CKD patients: fifteen years of experience 1.523
Cardiorenal syndrome type 4 (CRS 4) associated with anaemia long term survival analysis 1.481
Exercise-Associated hyponatremia: 2017 update 1.465
Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update 1.439
Genome-Wide Analysis Studies and Chronic Kidney Disease 1.428
Outcomes of Pregnancies after Kidney Transplantation: Lessons Learned from CKD. A Comparison of Transplanted, Nontransplanted Chronic Kidney Disease Patients and Low-Risk Pregnancies: A Multicenter Nationwide Analysis 1.340
Metformin associated lactic acidosis: a case series of 28 patients treated with sustained low-efficiency dialysis (SLED) and long-term follow-up 1.331
Efficiency and nutritional parameters in an elderly high risk population on hemodialysis and hemodiafiltration in Italy and France: different treatments with similar names? 1.266
Summary of the International Conference on Onco-Nephrology: an emerging field in medicine 1.184
Opening an onconephrology clinic: recommendations and basic requirements 1.173
Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group 1.165
Multicenter study on parathyroidectomy (PTX) in Italy: preliminary results 1.156
The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis 1.136
A multicenter study of the predictive value of crescents in IgA nephropathy 1.134
Treatment of primary membranous nephropathy: where are we now? 1.129
Compliance, illiteracy and low-protein diet: multiple challenges in CKD and a case of self-empowerment 1.113
Hypertension in CKD Pregnancy: a Question of Cause and Effect (Cause or Effect? This Is the Question) 1.082
Pregnancy outcomes after kidney graft in Italy: are the changes over time the result of different therapies or of different policies? A nationwide survey (1978-2013) 1.050
Pregnancy in Chronic Kidney Disease: questions and answers in a changing panorama 1.022
Patient Selection and Timing of Continuous Renal Replacement Therapy 1.005
Diabetic kidney disease: A syndrome rather than a single disease 1.003
Standardized reporting of monoclonal iImmunoglobulin-associated renal diseases: Recommendations from a Mayo Clinic/Renal Pathology Society Working Group 963
Pregnancy in dialysis patients in the new millennium: a systematic review and meta-regression analysis correlating dialysis schedules and pregnancy outcomes 958
The children of dialysis: live-born babies from on-dialysis mothers in Italy--an epidemiological perspective comparing dialysis, kidney transplantation and the overall population 925
CVVHD treatment with CARPEDIEM: small solute clearance at different blood and dialysate flows with three different surface area filter configurations 904
Glomerular diseases and cancer: evaluation of underlying malignancy 868
FSGS: from pathogenesis to the histological lesion 843
Diagnosis of complement alternative pathway disorders 822
Corticosteroid treatment influences TA-Proteinuria and renal survival in IgA nephropathy 804
Changes in proteinuria and side effects of corticosteroids alone or in combination with azathioprine at different stages of IgA nephropathy 783
Sodium and Volume Disorders in Advanced Chronic Kidney Disease 779
Prevalence of CKD and its relationship to eGFR-related genetic loci and clinical risk factors in the SardiNIA study cohort 746
Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens 731
PRF1 mutation alters immune system activation, inflammation, and risk of autoimmunity 728
Linee guida alla prevenzione, diagnosi e terapia delle sindromi di danno renale acuto: versione italiana delle KDIGO, integrata con le nuove evidenze e i commentari internazionali = Guidelines for the prevention, diagnosis and treatment of acute kidney injury syndromes: Italian version of KDIGO, integrated with new evidence and international commentaries 718
Clinicopathologic predictors of renal outcomes in light chain cast nephropathy: a multicenter retrospective study 705
Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments 695
Rituximab versus steroids and cyclophosphamide for the treatment of primary membranous nephropathy: Protocol of a pilot randomised controlled trial 692
How Genetics Can Improve Clinical Practice in Chronic Kidney Disease: From Bench to Bedside 673
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes 660
Multi-Autoantibody Signature and Clinical Outcome in Membranous Nephropathy 642
History of Preeclampsia in Patients Undergoing a Kidney Biopsy: A Biphasic, Multiple-Hit Pathogenic Hypothesis 635
COVID-19 Vaccine Hesitancy in Patients on Dialysis in Italy and France 629
Hyperkalemia in hemodialysis patients 612
Extensive proximal tubular necrosis without recovery following the ingestion of Amanita phalloides: a case report 604
The impact of the secondary infections in ICU patients affected by COVID-19 during three different phases of the SARS-CoV-2 pandemic 603
Unexpected Outcomes of Renal Function after Radical Nephrectomy: Histology Relevance along with Clinical Aspects 594
Standard immunosuppressive therapy of immune-mediated glomerular diseases 582
Chronic kidney disease of undetermined etiology around the world 579
Approach to Diagnosis and Treatment of Hypercalcemia in a Patient With Malignancy 556
The relationship between uremic toxins and symptoms in older men and women with advanced chronic kidney disease 553
Tossicità renale da farmaci antineoplastici 532
Kidney Failure Prediction Models: A Comprehensive External Validation Study in Patients with Advanced CKD 528
Renal Function Outcomes in Metastatic Non-Small-Cell Lung Carcinoma Patients Treated with Chemotherapy or Immune Checkpoint Inhibitors: An Unexpected Scenario 527
Immunosuppressive treatment in dialysis patients 521
Prevalence of hypertension in a large cohort of Italian hemodialysis patients: results of a cross-sectional study 488
COMPASS criteria applied to a contemporary cohort of unselected patients with stable coronary artery diseases: insights from the START registry 487
IgA nephropathy with severe chronic renal failure: A randomized controlled trial of corticosteroids and azathioprine 485
Ramipril and cardiovascular outcomes in patients on maintenance hemodialysis. The ARCADIA multicenter randomized controlled trial 477
Addition of azathioprine to corticosteroids does not benefit patients with IgA nephropathy 468
Development and testing of an artificial intelligence tool for predicting end-stage kidney disease in patients with immunoglobulin A nephropathy 460
Classification and Management of MGRS Related Diseases 457
Any reduction in maternal kidney mass makes a difference during pregnancy in gestational and fetal outcome 452
DIAGNOSIS AND PREVALENCE OF NON DIABETIC RENAL DISEASES IN PATIENTS WITH DIABETES: A TWENTY YEARS EXPERIENCE 447
Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome 443
La Nefrologia in Tasca 430
Transplant Candidate with Cancer: Should We Proceed? 428
CLINICAL PRESENTATION AND OUTCOME OF PATIENTS AFFECTED BY SYSTEMIC AMYLOIDOSIS WITH PREDOMINANT RENAL INVOLVEMENT: A 10 YEAR, SINGLE CENTRE EXPERIENCE 422
Predicting Kidney Failure, Cardiovascular Disease and Death in Advanced CKD Patients 412
Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial 411
Association Between Renal Function and Troponin T Over Time in Stable Chronic Kidney Disease Patients 404
Application of the International IgA Nephropathy Prediction Tool one or two years post-biopsy 403
Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool 401
Risk factors and action thresholds for the novel coronavirus pandemic. Insights from the Italian Society of Nephrology COVID-19 Survey 397
Quantifying duration of proteinuria remission and association with clinical outcome in IgA nephropathy 389
Mediterranean spotted fever with acute renal failure stimulating a relapse in C-ANCA vasculitis 386
Clinical outcomes, pharmacological treatment, and quality of life of patients with stable coronary artery diseases managed by cardiologists: 1-year results of the START study 382
Reproducibility of the Oxford classification of immunoglobulin A nephropathy, impact of biopsy scoring on treatment allocation and clinical relevance of disagreements: Evidence from the VALidation of IGA study cohort 376
An Integrated Multidisciplinary Approach to the Care of Renal Cancer Patients Undergoing Nephrectomy 376
METFORMIN-ASSOCIATED LACTIC ACIDOSIS (MALA): A SINGLE CENTRE EXPERIENCE ON 14 PATIENTS 363
Mayo Clinic consensus report on membranous nephropathy: proposal for a novel classification 361
Renal function at follow-up in a cohort of patients who had shown reduced glomerular filtration rate during long-term treatment with lithium 358
[A new clinicopathological classification for IgA nephropathy (the Oxford IgA nephropathy classification)]. 358
Parathyroidectomy and survival in a cohort of Italian dialysis patients: results of a multicenter, observational, prospective study 356
Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy 347
The role of rituximab in the treatment of ANCA-associated systemic vasculitis 346
Treating elderly people with diabetes and stages 3 and 4 chronic kidney disease. 340
Risk for chronic kidney disease in the general population Italian reports for World Kidney Days 2007-2009 340
L'utilita' delle biopsie protocollari nel trapianto di rene: pro e contro.[The usefulness of protocol biopsies after kidney transplant: pros and cons] 333
Radiopacity of Sodium Zirconium Cyclosilicate in Computed Tomography: a case of a patient with Hyperkalemia and kidney disease 326
Totale 91.098
Salva come PNG Salva come JPEG
Categoria #
all - tutte 149.257
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 149.257
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.487 0 0 0 0 0 0 0 0 0 979 853 655
2021/20226.217 720 494 245 360 463 549 326 238 408 484 1.036 894
2022/20238.620 796 854 908 604 876 838 473 742 613 564 916 436
2023/202412.187 403 413 448 630 1.134 2.215 2.376 814 645 613 1.121 1.375
2024/202522.698 3.917 5.284 3.102 3.253 1.643 2.578 1.495 136 334 371 267 318
2025/20268.564 637 349 1.288 1.056 780 708 1.674 592 684 796 0 0
Totale 100.251